#ECITalks: Melissa Stewart from AML U54 @ohsuknight.bsky.social shared how combining venetoclax with the CDK4/6 inhibitor palbociclib overcomes resistance in RAS-mutant AML, reducing tumor burden, improving survival, and reshaping protein synthesis pathways.
#ARTNetScientificRetreat2025